The importance of VEGF and its receptors Flt1 and Flk1, along with ERK1/2 and MMP2 in glioma angiogenesis and the inhibitory effects of GLA on these proteins' expression suggested the possibility that angiogenesis could be modified in the GLA-treated tumours. The gene discussed is FLT1; the disease is central nervous system cancer.